Identifying Patients at High Risk for Stroke Despite Anticoagulation
Authors:
Top Cited Papers
- 1 December 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 41 (12) , 2731-2738
Abstract
Background and Purpose— The risk of stroke in patients with atrial fibrillation (AF) is not homogeneous, and various clinical risk factors have informed the development of stroke risk stratification schemes (RSS). Among anticoagulated cohorts, the emphasis should be on the identification of patients who remain at high risk for stroke despite anticoagulation. Methods— We investigated predictors of thromboembolism (TE) risk in an anticoagulated AF clinical trial cohort (n=7329 subjects) and tested the predictive value of contemporary RSS in this cohort: CHADS 2 , Framingham, NICE 2006, American College of Cardiology/American Heart Association/European Society of Cardiology 2006, the 8th American College of Chest Physicians guidelines and the CHA 2 DS 2 -VASc schemes. Results— On multivariate analysis, significant predictors of TE were stroke/TIA (hazard ratio [HR], 2.24; P P =0.0002), coronary artery disease (HR, 1.52; P =0.0047), and smoking (HR, 2.10; P =0.0005), whereas reported alcohol use (HR, 0.70; P =0.02) was protective. Comparison of contemporary RSS demonstrated variable classification of AF patients into risk strata, although c -statistics for TE were broadly similar among the RSS tested and varied between 0.575 (NICE 2006) and 0.647 (CHA 2 DS 2 -VASc). CHA 2 DS 2 -VASc classified 94.2% as being at high risk, whereas most other RSS categorized two-thirds as being at high risk. Of the 184 TE events, 181 (98.4%) occurred in patients identified as being at high risk by the CHA 2 DS 2 -VASc schema. There was a stepwise increase in TE with increasing CHA 2 DS 2 -VASc score ( P trend 2 DS 2 -VASc was 99.5%. Conclusion— Coronary artery disease and smoking are additional risk factors for TE in anticoagulated AF patients, whereas alcohol use appears protective. Of the contemporary stroke RSS, the CHA 2 DS 2 -VASc scheme correctly identified the greatest proportion of AF patients at high risk, despite the similar predictive ability of most RSS evidenced by the c -statistic.Keywords
This publication has 35 references indexed in Scilit:
- Stroke risk in atrial fibrillation patients on warfarinThrombosis and Haemostasis, 2009
- Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implicationsEuropean Heart Journal, 2008
- Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial FibrillationStroke, 2008
- Comparison of Risk Stratification Schemes to Predict Thromboembolism in People With Nonvalvular Atrial FibrillationJACC, 2008
- Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness dataThrombosis and Haemostasis, 2008
- Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?Stroke, 2007
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial FibrillationCirculation, 2006
- Cardiovascular Risk Factors and 5-Year Mortality in the Copenhagen Stroke StudyCerebrovascular Diseases, 2006
- Comparison of outcomes of patients with symptomatic peripheral artery disease with and without atrial fibrillation (the West Birmingham Atrial Fibrillation Project)The American Journal of Cardiology, 2004
- Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trialThe Lancet, 2003